857 related articles for article (PubMed ID: 18058612)
21. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
Hüseyin A; Sancak B; Arikan S
Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
[TBL] [Abstract][Full Text] [Related]
22. In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes.
Shams-Ghahfarokhi M; Shokoohamiri MR; Amirrajab N; Moghadasi B; Ghajari A; Zeini F; Sadeghi G; Razzaghi-Abyaneh M
Fitoterapia; 2006 Jun; 77(4):321-3. PubMed ID: 16690223
[TBL] [Abstract][Full Text] [Related]
23. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004].
Eloy O; Blanc V; Pina P; Gaudart A; Bressolle ML; Plainvert C; Decousser JW; Pangon B; Allouch PY;
Pathol Biol (Paris); 2006; 54(8-9):523-30. PubMed ID: 17029814
[TBL] [Abstract][Full Text] [Related]
24. Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest.
Chiu YS; Chang SC; Hsueh PR; Wang JL; Sun HY; Chen YC
J Microbiol Immunol Infect; 2006 Aug; 39(4):335-41. PubMed ID: 16926981
[TBL] [Abstract][Full Text] [Related]
25. Antifungal activities and action mechanisms of compounds from Tribulus terrestris L.
Zhang JD; Xu Z; Cao YB; Chen HS; Yan L; An MM; Gao PH; Wang Y; Jia XM; Jiang YY
J Ethnopharmacol; 2006 Jan; 103(1):76-84. PubMed ID: 16169173
[TBL] [Abstract][Full Text] [Related]
26. Antifungal activity of Zuccagnia punctata Cav.: evidence for the mechanism of action.
Svetaz L; Agüero MB; Alvarez S; Luna L; Feresin G; Derita M; Tapia A; Zacchino S
Planta Med; 2007 Aug; 73(10):1074-80. PubMed ID: 17628836
[TBL] [Abstract][Full Text] [Related]
27. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
[TBL] [Abstract][Full Text] [Related]
28. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.
Gualco L; Debbia EA; Bandettini R; Pescetto L; Cavallero A; Ossi MC; Schito AM; Marchese A
Int J Antimicrob Agents; 2007 Feb; 29(2):179-84. PubMed ID: 17175140
[TBL] [Abstract][Full Text] [Related]
29. Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species.
Sóczó G; Kardos G; McNicholas PM; Balogh E; Gergely L; Varga I; Kelentey B; Majoros L
J Antimicrob Chemother; 2007 Nov; 60(5):1004-9. PubMed ID: 17875607
[TBL] [Abstract][Full Text] [Related]
30. In vitro antifungal activity of extract and plumbagin from the stem bark of Diospyros crassiflora Hiern (Ebenaceae).
Dzoyem JP; Tangmouo JG; Lontsi D; Etoa FX; Lohoue PJ
Phytother Res; 2007 Jul; 21(7):671-4. PubMed ID: 17444575
[TBL] [Abstract][Full Text] [Related]
31. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
32. Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001-2006.
Metwally L; Walker MJ; Coyle PV; Hay RJ; Hedderwick S; McCloskey BV; O'Neill HJ; Webb CH; McMullan R
J Infect; 2007 Aug; 55(2):174-8. PubMed ID: 17560655
[TBL] [Abstract][Full Text] [Related]
33. Antifungal steroid saponins from Dioscorea cayenensis.
Sautour M; Mitaine-Offer AC; Miyamoto T; Dongmo A; Lacaille-Dubois MA
Planta Med; 2004 Jan; 70(1):90-2. PubMed ID: 14765305
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility to antifungal agents of Candida species isolated from paediatric and adult patients with haematological diseases.
Nawrot U; Nowicka J; Juszczak K; Gusin B
Mycoses; 2005 Nov; 48(6):385-90. PubMed ID: 16262874
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
[TBL] [Abstract][Full Text] [Related]
36. Effects of galanin message-associated peptide and neuropeptide Y against various non-albicans Candida strains.
Holub BS; Rauch I; Radner S; Sperl W; Hell M; Kofler B
Int J Antimicrob Agents; 2011 Jul; 38(1):76-80. PubMed ID: 21550784
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs.
Brito EH; Fontenelle RO; Brilhante RS; Cordeiro RA; Soares Júnior FA; Monteiro AJ; Sidrim JJ; Rocha MF
Vet J; 2007 Jul; 174(1):147-53. PubMed ID: 17188535
[TBL] [Abstract][Full Text] [Related]
38. Antifungal activity of fruit pulp extract from Psidium sartorianum.
Camacho-Hernández IL; Cisneros-Rodríguez C; Uribe-Beltrán MJ; Ríos-Morgan A; Delgado-Vargas F
Fitoterapia; 2004 Jun; 75(3-4):401-4. PubMed ID: 15159007
[TBL] [Abstract][Full Text] [Related]
39. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
40. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
